XML 160 R115.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE II - Condensed Financial Information of Registrant - Statements of Cash Flow (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Condensed Cash Flow Statements, Captions [Line Items]      
Net income available to common shareholders $ 2,132.5 $ 52.6 $ 68.3
Adjustments to reconcile net income after tax to net cash provided by operating activities:      
Revaluation of Fidelis MGU (1,707.1) 0.0 0.0
Net income attributable to non-controlling interests 0.0 9.7 10.0
Share compensation expense 27.6 10.8 9.8
Deferred tax benefit (86.5) (10.4) (26.4)
Net changes in assets and liabilities:      
Amounts due from Fidelis MGU (176.2) 0.0 0.0
Amounts due to Fidelis MGU 334.0 0.0 0.0
Other assets 34.6 (3.0) (6.6)
Other liabilities 16.6 23.3 (31.5)
Net cash provided by operating activities 495.2 741.4 345.8
Investing activities      
Net cash provided by/(used in) investing activities (834.9) 215.9 (1,085.5)
Financing activities      
Proceeds from issuance of common stock, net of issuance costs 89.4 0.0 318.2
Cumulative dividends on warrants (34.1) 0.0 0.0
Tax paid on withholding shares (50.6) 0.0 0.0
Repurchase of common shares 0.0 0.0 (320.9)
Dividends on common shares 0.0 (0.5) (2.1)
Net cash used in financing activities (106.9) (16.2) (18.2)
Net increase/(decrease) in cash, restricted cash, and cash equivalents (443.8) 931.9 (762.5)
Cash, restricted cash, and cash equivalents, beginning of year 1,407.9 476.0 1,238.5
Cash, restricted cash, and cash equivalents, end of year 964.1 1,407.9 476.0
Parent Company      
Condensed Cash Flow Statements, Captions [Line Items]      
Net income available to common shareholders 2,132.5 52.6 68.3
Adjustments to reconcile net income after tax to net cash provided by operating activities:      
Revaluation of Fidelis MGU (1,707.1) 0.0 0.0
Net income attributable to non-controlling interests (397.1) 105.7 (25.4)
Share compensation expense 27.6 10.8 9.8
Deferred tax benefit 2.6 (14.2) (21.3)
Net changes in assets and liabilities:      
Amounts due from Fidelis MGU (0.2) 0.0 0.0
Amounts due to Fidelis MGU (5.4) (14.9) 21.3
Other assets 3.0 (4.2) (0.4)
Other liabilities 12.6 (4.6) (1.5)
Net cash provided by operating activities 68.5 131.2 50.8
Investing activities      
Contributed capital to subsidiaries (90.0) 0.0 (75.0)
Net cash provided by/(used in) investing activities (90.0) 0.0 (75.0)
Financing activities      
Proceeds from issuance of common stock, net of issuance costs 89.4 0.0 318.2
Non-controlling interest share transactions (6.1) (18.2) 0.0
Repurchase of common shares 0.0 0.0 (320.9)
Dividends on common shares 0.0 (0.5) (2.1)
Net cash used in financing activities (1.4) (18.7) (4.8)
Net increase/(decrease) in cash, restricted cash, and cash equivalents (22.9) 112.5 (29.0)
Cash, restricted cash, and cash equivalents, beginning of year 127.6 15.1 44.1
Cash, restricted cash, and cash equivalents, end of year $ 104.7 $ 127.6 $ 15.1